Skip to main content
Top
Published in: Immunity & Ageing 1/2013

Open Access 01-12-2013 | Editorial

Sex, gender and immunosenescence: a key to understand the different lifespan between men and women?

Authors: Calogero Caruso, Giulia Accardi, Claudia Virruso, Giuseppina Candore

Published in: Immunity & Ageing | Issue 1/2013

Login to get access

Excerpt

Gender and sex are known to be associated with longevity. While males are usually stronger, females live longer. In the Western world, the life expectancy of individual born between 2005 and 2010 is 80.4 for women and 73.4 for men [1]. Potential factors have been examined to explain this disagreement. It is possible distinguish advantage in longevity related to biological traits and factors related to socio-cultural characteristics of the population. Males and females have different behavioral tendencies, social responsibilities and expectation. So, differences in mortality between men and women can be not only a matter of sex that refers to biological differences, but also a matter of “socially constructed sex”, i.e. gender [2, 3]. …
Literature
2.
go back to reference Candore G, Balistreri RC, Colonna-Romano G, Lio D, Listì F, Vasto S, Caruso C: Gender-Related Immune-Inflammatory Factors, Age-Related Diseases, and Longevity. Rejuvenation Res. 2010, 13: 292-7. 10.1089/rej.2009.0942.CrossRefPubMed Candore G, Balistreri RC, Colonna-Romano G, Lio D, Listì F, Vasto S, Caruso C: Gender-Related Immune-Inflammatory Factors, Age-Related Diseases, and Longevity. Rejuvenation Res. 2010, 13: 292-7. 10.1089/rej.2009.0942.CrossRefPubMed
3.
go back to reference Pan Z, Chang C: Gender and the regulation of longevity: Implication for autoimmunity. Autoimmunity Review. 2012, 11: 6-7.CrossRef Pan Z, Chang C: Gender and the regulation of longevity: Implication for autoimmunity. Autoimmunity Review. 2012, 11: 6-7.CrossRef
4.
go back to reference Lawrence DA, McCabe MJ: Immunomodulation by metals. Int Immunopharmacol. 2002, 2: 293-302. 10.1016/S1567-5769(01)00180-1.CrossRefPubMed Lawrence DA, McCabe MJ: Immunomodulation by metals. Int Immunopharmacol. 2002, 2: 293-302. 10.1016/S1567-5769(01)00180-1.CrossRefPubMed
5.
go back to reference Vina J, Gambini J, Lopez-Grueso R, Abdelaziz KM, Jove M, Borras C: Females live longer than males: role of oxidative stress. Curr Pharm Des. 2011, 17: 3959-65. 10.2174/138161211798764942.CrossRefPubMed Vina J, Gambini J, Lopez-Grueso R, Abdelaziz KM, Jove M, Borras C: Females live longer than males: role of oxidative stress. Curr Pharm Des. 2011, 17: 3959-65. 10.2174/138161211798764942.CrossRefPubMed
6.
go back to reference Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999, 340: 1801-11. 10.1056/NEJM199906103402306.CrossRefPubMed Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999, 340: 1801-11. 10.1056/NEJM199906103402306.CrossRefPubMed
7.
go back to reference Vasto S, Scapagnini G, Bulati M, Candore G, Castiglia L, Colonna-Romano G, Lio D, Nuzzo D, Pellicano M, Rizzo C, Ferrara N, Caruso C: Biomarkers of ageing. Front Biosci (Schol Ed). 2010, 2: 392-402.CrossRef Vasto S, Scapagnini G, Bulati M, Candore G, Castiglia L, Colonna-Romano G, Lio D, Nuzzo D, Pellicano M, Rizzo C, Ferrara N, Caruso C: Biomarkers of ageing. Front Biosci (Schol Ed). 2010, 2: 392-402.CrossRef
8.
go back to reference Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T: Slower immune system aging in women versus men in the Japanese population. Immun Ageing. 2013, 10: 19-10.1186/1742-4933-10-19.PubMedCentralCrossRefPubMed Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T: Slower immune system aging in women versus men in the Japanese population. Immun Ageing. 2013, 10: 19-10.1186/1742-4933-10-19.PubMedCentralCrossRefPubMed
9.
go back to reference Balistreri CR, Caruso C, Listì F, Colonna-Romano G, Lio D, Candore G: LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects. Mech Ageing Dev. 2011, 132: 86-92. 10.1016/j.mad.2010.12.005.CrossRefPubMed Balistreri CR, Caruso C, Listì F, Colonna-Romano G, Lio D, Candore G: LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects. Mech Ageing Dev. 2011, 132: 86-92. 10.1016/j.mad.2010.12.005.CrossRefPubMed
10.
go back to reference Oertelt-Prigione S: The influence of sex and gender on the immune response. Autoimmun Rev. 2012, 11: A479-85. 10.1016/j.autrev.2011.11.022.CrossRefPubMed Oertelt-Prigione S: The influence of sex and gender on the immune response. Autoimmun Rev. 2012, 11: A479-85. 10.1016/j.autrev.2011.11.022.CrossRefPubMed
11.
go back to reference Viña J, Borrá C, Gambini J, Sastre J, Pallardó FV: Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ. 2005, pe17- Viña J, Borrá C, Gambini J, Sastre J, Pallardó FV: Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ. 2005, pe17-
12.
go back to reference Caruso C, Candore G, Romano GC, Lio D, Bonafè M, Valensin S, Franceschi C: Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mech Ageing Dev. 2001, 122: 445-62. 10.1016/S0047-6374(00)00255-4.CrossRefPubMed Caruso C, Candore G, Romano GC, Lio D, Bonafè M, Valensin S, Franceschi C: Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mech Ageing Dev. 2001, 122: 445-62. 10.1016/S0047-6374(00)00255-4.CrossRefPubMed
13.
go back to reference Ansar AS, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985, 121: 531-551. Ansar AS, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985, 121: 531-551.
15.
go back to reference Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, Jeune B, Andersen-Ranberg K, Vaupel JW, Orstavik KH: X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood. 2000, 95: 2449-51.PubMed Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, Jeune B, Andersen-Ranberg K, Vaupel JW, Orstavik KH: X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood. 2000, 95: 2449-51.PubMed
16.
go back to reference Ellegren H, Parsch J: The evolution of sex-biased genes and sex-biased gene expression. Nat Rev Genet. 2007, 8: 689-98. 10.1038/nrg2167.CrossRefPubMed Ellegren H, Parsch J: The evolution of sex-biased genes and sex-biased gene expression. Nat Rev Genet. 2007, 8: 689-98. 10.1038/nrg2167.CrossRefPubMed
17.
go back to reference Barrett EL, Richardson DS: Sex differences in telomeres and lifespan. Aging Cell. 2011, 10: 913-21. 10.1111/j.1474-9726.2011.00741.x.CrossRefPubMed Barrett EL, Richardson DS: Sex differences in telomeres and lifespan. Aging Cell. 2011, 10: 913-21. 10.1111/j.1474-9726.2011.00741.x.CrossRefPubMed
18.
go back to reference Anogeianaki A, Castellani ML, Tripodi D, Toniato E, De Lutiis MA, Conti F, Felaco P, Fulcheri M, Theoharides TC, Galzio R, Caraffa A, Antinolfi P, Cuccurullo C, Ciampoli C, Felaco M, Cerulli G, Pandolfi F, Sabatino G, Neri G, Shaik-Dasthagirisaheb YB: Vitamins and mast cells. Int J Immunopathol Pharmacol. 2010, 23: 991-6.PubMed Anogeianaki A, Castellani ML, Tripodi D, Toniato E, De Lutiis MA, Conti F, Felaco P, Fulcheri M, Theoharides TC, Galzio R, Caraffa A, Antinolfi P, Cuccurullo C, Ciampoli C, Felaco M, Cerulli G, Pandolfi F, Sabatino G, Neri G, Shaik-Dasthagirisaheb YB: Vitamins and mast cells. Int J Immunopathol Pharmacol. 2010, 23: 991-6.PubMed
19.
go back to reference Fraker PJ, King LE: Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004, 24: 277-98. 10.1146/annurev.nutr.24.012003.132454.CrossRefPubMed Fraker PJ, King LE: Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004, 24: 277-98. 10.1146/annurev.nutr.24.012003.132454.CrossRefPubMed
20.
go back to reference Bonham M, O’Connor JM, Hannigan BM, Strain JJ: The immune system as a physiological indicator of marginal copper status?. Br J Nutr. 2002, 87: 393-403. 10.1079/BJN2002558.CrossRefPubMed Bonham M, O’Connor JM, Hannigan BM, Strain JJ: The immune system as a physiological indicator of marginal copper status?. Br J Nutr. 2002, 87: 393-403. 10.1079/BJN2002558.CrossRefPubMed
21.
go back to reference Ojanuga DN, Gilbert C: Women’s access to health care in developing countries. Soc Sci Med. 1992, 35: 613-7. 10.1016/0277-9536(92)90355-T.CrossRefPubMed Ojanuga DN, Gilbert C: Women’s access to health care in developing countries. Soc Sci Med. 1992, 35: 613-7. 10.1016/0277-9536(92)90355-T.CrossRefPubMed
22.
go back to reference Franceschi C, Motta L, Motta M, Malaguarnera M, Capri M, Vasto S, Candore G, Caruso C, IMUSCE: The extreme longevity: the state of the art in Italy. Exp Gerontol. 2008, 43: 45-52. 10.1016/j.exger.2007.06.006.CrossRefPubMed Franceschi C, Motta L, Motta M, Malaguarnera M, Capri M, Vasto S, Candore G, Caruso C, IMUSCE: The extreme longevity: the state of the art in Italy. Exp Gerontol. 2008, 43: 45-52. 10.1016/j.exger.2007.06.006.CrossRefPubMed
Metadata
Title
Sex, gender and immunosenescence: a key to understand the different lifespan between men and women?
Authors
Calogero Caruso
Giulia Accardi
Claudia Virruso
Giuseppina Candore
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2013
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-10-20

Other articles of this Issue 1/2013

Immunity & Ageing 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.